Berberine‑attenuated monocyte adhesion to endothelial cells induced by oxidized low‑density lipoprotein via inhibition of adhesion molecule expression

Huang,Zhouqing; Cai,Xueli; Li,Sheng; Zhou,Hao; Chu,Maoping; Shan,Peiren; Huang,Weijian

doi:10.3892/mmr.2012.1236

Berberine‑attenuated monocyte adhesion to endothelial cells induced by oxidized low‑density lipoprotein via inhibition of adhesion molecule expression

Authors:
- Zhouqing Huang
- Xueli Cai
- Sheng Li
- Hao Zhou
- Maoping Chu
- Peiren Shan
- Weijian Huang
View Affiliations

Affiliations: Cardiac Center, The First Affiliated Hospital of Wenzhou Medical College, Zhejiang 325000, P.R. China
Published online on: December 14, 2012 https://doi.org/10.3892/mmr.2012.1236
Pages: 461-465

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Recruitment of monocytes to endothelial cells is important during early stages of atherosclerosis development. This process is predominantly mediated by cellular adhesion molecules, including vascular cell adhesion molecule‑1 (VCAM‑1) and intercellular adhesion molecule‑1 (ICAM‑1), which are expressed by activated endothelial cells in response to a number of inflammatory stimuli, including oxidized low‑density lipoprotein (oxLDL). Previous studies have demonstrated that berberine, a natural extract from Rhizoma coptidis, prevents oxLDL‑induced endothelial cellular apoptosis. However, its effect on the adhesion of monocytes to endothelial cells and the mechanism associated with this process remains unclear. In the present study, berberine was revealed to markedly reduce oxLDL‑induced monocyte adhesion to human umbilical vein endothelial cells. In addition, the inhibitory mechanism of berberine was associated with suppression of adhesion molecule expression, including VCAM‑1 and ICAM‑1. Results indicate that berberine plays a protective role in the early stages of atherosclerosis.

View Figures

View References

1	Price DT and Loscalzo J: Cellular adhesion molecules and atherogenesis. Am J Med. 107:85–97. 1999. View Article : Google Scholar : PubMed/NCBI
2	Cominacini L, Garbin U, Pasini AF, et al: Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radic Biol Med. 22:117–127. 1997. View Article : Google Scholar : PubMed/NCBI
3	Jeng JR, Chang CH, Shieh SM and Chiu HC: Oxidized low-density lipoprotein enhances monocyte-endothelial cell binding against shear-stress-induced detachment. Biochim Biophys Acta. 1178:221–227. 1993. View Article : Google Scholar : PubMed/NCBI
4	Khan BV, Parthasarathy SS, Alexander RW and Medford RM: Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest. 95:1262–1270. 1995. View Article : Google Scholar
5	Takei A, Huang Y and Lopes-Virella MF: Expression of adhesion molecules by human endothelial cells exposed to oxidized low density lipoprotein. Influences of degree of oxidation and location of oxidized LDL. Atherosclerosis. 154:79–86. 2001. View Article : Google Scholar : PubMed/NCBI
6	Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:801–809. 1993. View Article : Google Scholar : PubMed/NCBI
7	Blankenberg S, Barbaux S and Tiret L: Adhesion molecules and atherosclerosis. Atherosclerosis. 170:191–203. 2003. View Article : Google Scholar
8	Takahashi M, Ikeda U, Masuyama J, Kitagawa S, Kasahara T, Shimpo M, Kano S and Shimada K: Monocyte-endothelial cell interaction induces expression of adhesion molecules on human umbilical cord endothelial cells. Cardiovasc Res. 32:422–429. 1996. View Article : Google Scholar : PubMed/NCBI
9	Hansson GK: Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol. 21:1876–1890. 2001. View Article : Google Scholar
10	Ikram M: A review on the chemical and pharmacological aspects of genus Berberis. Planta Med. 28:353–358. 1975. View Article : Google Scholar : PubMed/NCBI
11	Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA and Lewis K: Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci USA. 97:1433–1437. 2000.PubMed/NCBI
12	Kong W, Wei J, Abidi P, et al: Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 10:1344–1351. 2004. View Article : Google Scholar : PubMed/NCBI
13	Yin J, Xing H and Ye J: Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 57:712–717. 2008. View Article : Google Scholar : PubMed/NCBI
14	Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC and Ho TY: Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells. Pharmacol Res. 56:193–201. 2007. View Article : Google Scholar
15	Huang Z, Wang L, Meng S, Wang Y, Chen T and Wang C: Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages. Int J Cardiol. 146:153–158. 2011. View Article : Google Scholar : PubMed/NCBI
16	Hsieh YS, Kuo WH, Lin TW, Chang HR, Lin TH, Chen PN and Chu SC: Protective effects of berberine against low-density lipoprotein (LDL) oxidation and oxidized LDL-induced cytotoxicity on endothelial cells. J Agric Food Chem. 55:10437–10445. 2007. View Article : Google Scholar : PubMed/NCBI
17	Pamukcu B, Lip GY, Devitt A, Griffiths H and Shantsila E: The role of monocytes in atherosclerotic coronary artery disease. Ann Med. 42:394–403. 2010. View Article : Google Scholar : PubMed/NCBI
18	Mitra S, Deshmukh A, Sachdeva R, Lu J and Mehta JL: Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am J Med Sci. 342:135–142. 2011. View Article : Google Scholar : PubMed/NCBI
19	Mitra S, Goyal T and Mehta JL: Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther. 25:419–429. 2011. View Article : Google Scholar : PubMed/NCBI
20	Fotis L, Agrogiannis G, Vlachos IS, et al: Intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 at the early stages of atherosclerosis in a rat model. In Vivo. 26:243–250. 2012.PubMed/NCBI
21	Chen H, Li D, Saldeen T and Mehta JL: Transforming growth factor-beta(1) modulates oxidatively modified LDL-induced expression of adhesion molecules: role of LOX-1. Circ Res. 89:1155–1160. 2001. View Article : Google Scholar : PubMed/NCBI
22	Li D, Chen H, Romeo F, Sawamura T, Saldeen T and Mehta JL: Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. J Pharmacol Exp Ther. 302:601–605. 2002. View Article : Google Scholar
23	Steffens S and Mach F: Inflammation and atherosclerosis. Herz. 29:741–748. 2004. View Article : Google Scholar
24	Anis KV, Rajeshkumar NV and Kuttan R: Inhibition of chemical carcinogenesis by berberine in rats and mice. J Pharm Pharmacol. 53:763–768. 2001. View Article : Google Scholar : PubMed/NCBI
25	Yin J, Gao Z, Liu D, Liu Z and Ye J: Berberine improves glucose metabolism through induction of glycolysis. Am J Physiol Endocrinol Metab. 294:E148–E156. 2008. View Article : Google Scholar : PubMed/NCBI
26	Chen FL, Yang ZH, Liu Y, et al: Berberine inhibits the expression of TNFalpha, MCP-1 and IL-6 in AcLDL-stimulated macrophages through PPARgamma pathway. Endocrine. 33:331–337. 2008. View Article : Google Scholar : PubMed/NCBI
27	Newby AC: Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol. 28:2108–2114. 2008. View Article : Google Scholar : PubMed/NCBI